ThinkSabio

$CSTL

$35.81▲ -0.1% YTD

4 SEC 13D/G filings tracked · Last updated Sep 28, 2026

Filing History
News
CSTL ▼ -0.1% - Castle Biosciences, Inc.
CP $35.81▲ -0.1%Sep 28, 2026 · ThinkSabio Blog

$CSTL CSTL - New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esopha…

News
CSTL ▼ -0.1% - Castle Biosciences, Inc.
CP $35.81▲ -0.1%Sep 28, 2026 · ThinkSabio Blog

$CSTL New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus…

News
CSTL ▼ -0.3% - Castle Biosciences, Inc.
CP $34.70▲ -0.3%Sep 24, 2026 · ThinkSabio Blog

$CSTL CSTL - New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx…

News
CSTL ▼ -1.1% - Castle Biosciences, Inc.
CP $32.31▲ -1.1%Sep 9, 2026 · ThinkSabio Blog

$CSTL CSTL - JAAD Publication Shows Improved Performance of DecisionDx®-SCC…